Why Baby Bunting, Carsales, GWA, and Imugene shares are racing higher

These ASX shares are starting the week strongly.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to start the week with a disappointing decline. The benchmark index is currently down 0.9% to 7,272.1 points.

Four ASX shares that are not letting that hold them back are listed below. Here's why they are rising:

An investor sits at her desk and stretches her arms above her head in delight.

Image source: Getty Images

Baby Bunting Group Ltd (ASX: BBN)

The Baby Bunting share price is up 9% to $2.28. Investors have been buying this baby products retailer's shares after analysts at Morgans upgraded them to an add rating with a $2.50 price target. The broker made the move after increasing its earnings estimates to reflect cost reductions and a better sales outlook.

Carsales.Com Ltd (ASX: CAR)

The Carsales share price is up 6% to $26.11. This follows the release of the auto listings company's FY 2023 results. Carsales reported an 18% increase in pro forma revenue and a 43% lift in adjusted net profit after tax to $278.2 million. Looking ahead, management expects "to deliver good growth in Revenue and [pro forma] EBITDA in FY24" and an "expansion in the carsales Group EBITDA margin."

GWA Group Ltd (ASX: GWA)

The GWA share price is up 7% to $2.06. This has been driven by the release of the building fittings company's full-year results. GWA reported a 22.7% increase in statutory net profit to $43.2 million. Management commented: "GWA delivered a solid result for FY23 within a rapidly evolving operating environment that comprised two distinct halves."

Imugene Limited (ASX: IMU)

The Imugene share price is up 3.5% to 9.2 cents. This morning, this immuno-oncology company announced that its Phase 1 MAST (metastatic advanced solid tumours) trial evaluating the safety of novel cancer-killing virus CF33- hNIS (VAXINIA) has cleared the cohort 3 intratumoral (IT) arm of the monotherapy dose escalation study.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Carsales.com. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Three men stand on a winner's podium with medals around their necks and their hands raised in triumph.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a lukewarm but positive start to the trading week today.

Read more »

Concept image of a businessman riding a bull on an upwards arrow.
Healthcare Shares

How CSL shares skyrocketed 39% in August

Investors sent CSL shares rocketing 39% in August. But why?

Read more »

Hands reaching high for a trophy with a sunset in the background.
Share Gainers

The 5 best ASX 200 stocks to buy and hold in August revealed

Investors sent these five ASX 200 stocks rocketing 35% to 44% in August. But why?

Read more »

Three children wearing athletic short and singlets stand side by side on a running track wearing medals around their necks and standing with their hands on their hips.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a bleak start to the week this Monday.

Read more »

An old-fashioned panel of judges each holding a card with the number 10
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the week for investors this Friday.

Read more »

Man rocketing in the sky.
Share Gainers

3 ASX 200 stocks, including Paladin Energy, storming higher on earnings results this week

Investors sent Paladin Energy shares and these two popular ASX 200 stocks soaring following strong earnings results.

Read more »

Three rock climbers hang precariously off a steep cliff face, each connected to the other with the higher person holding on and the two below them connected by their arms and rope but not making contact with the cliff face.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a rather nasty Thursday session for investors.

Read more »

Three women athletes lie flat on a running track as though they have had a long hard race where they have fought hard but lost the event.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a disappointing showing from the market this hump day.

Read more »